Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > News

<< Previous

Bullboard Posts

Next >>

Comment by Tritoonon Mar 06, 2010 5:23am

483 Views

Post# 16850958

RE: News

Three news releases this week, seems halo wants to speed things up.

One person resigned, three were added to the BOD. An IR firm has been hired. All are extra compensated with options, exercisable at 0.10. I would have preferred that the exercise price had been somewhere between 0.20 and 0.30, which would have given me a more comfortable level of confidence. So the need to get them in the money would have been greater. But hey, I wish the options are in the money deep within weeks/months.

Also the company stated that a new era for halo is starting. They are drilling on several targets. Lets hope the results are better then the market is expecting. Lets hope that halo can build a nice resource so this low share price is history,

greetings
Tritoon

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading